Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abatacept + MTX vs MTX Alone in Active Rheumatoid Arthritis
NCT01758198Phase 4Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Apr 2013
- Primary completion
- Dec 2016
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 4 trial of abatacept in rheumatoid arthritis (RA), sponsored by Bristol Myers Squibb. Started Apr 2013; status: completed.
02
Drugs
abatacept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01758198.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01758198.